Company intelligence / Profile preview

Icarus Healthcare

Fairfield, Connecticut, United States

Ownership: Private
Development stage: Other

Overview

Icarus Healthcare is a specialized biotechnology company focused on developing innovative drug delivery systems and therapeutics for ophthalmic conditions, particularly glaucoma. The company's core technology involves a proprietary sustained-release platform designed to improve patient compliance and therapeutic outcomes by providing long-lasting intraocular pressure reduction. Their lead programs utilize novel formulations of established compounds, such as carbonic anhydrase inhibitors, delivered via minimally invasive methods. By addressing the limitations of daily eye drop regimens, Icarus Healthcare aims to prevent vision loss associated with chronic ocular diseases.

Therapeutic areas: Ophthalmology
Modalities: Small moleculeDeviceHydrogel-based drug delivery therapy
Industry: Biotech

Beyond the preview

Go deeper on Icarus Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Icarus Healthcare.

Explore the full profile